Amphastar Pharmaceuticals, Inc. Amortization of Intangible Assets
Amphastar Pharmaceuticals, Inc. (AMPH) reported Amortization of Intangible Assets of $12.54 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-08-06
- Amphastar Pharmaceuticals, Inc. amortization of intangible assets for the quarter ending 2026-06-30 was $6.27M, a 0.00% change year-over-year.
- Amphastar Pharmaceuticals, Inc. amortization of intangible assets for the quarter ending 2026-03-31 was $6.27M, a 0.48% increase year-over-year.
- Amphastar Pharmaceuticals, Inc. amortization of intangible assets for the quarter ending 2025-12-31 was $6.27M, a 1.47% increase year-over-year.
- Amphastar Pharmaceuticals, Inc. amortization of intangible assets for the quarter ending 2025-09-30 was $6.27M, a 1.46% increase year-over-year.
- Amphastar Pharmaceuticals, Inc. amortization of intangible assets for fiscal 2025 was $25.05M, a 1.34% increase from fiscal 2024.
- Amphastar Pharmaceuticals, Inc. amortization of intangible assets for fiscal 2024 was $24.72M, a 92.66% increase from fiscal 2023.
- Amphastar Pharmaceuticals, Inc. amortization of intangible assets for fiscal 2023 was $12.83M, a 1244.86% increase from fiscal 2022.
- Amphastar Pharmaceuticals, Inc. amortization of intangible assets for fiscal 2022 was $954.00K, a 10.92% decline from fiscal 2021.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 3 month as first filed | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 6 month as first filed | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 9 month as first filed | Amortization of Intangible Assets 12 month | Amortization of Intangible Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $6.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $12.54M 10-Q · filed 2026-08-06 | $18.81M derived: sum of 3 quarters · filed 2026-08-06 | $25.08M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $6.27M 10-Q · filed 2026-05-07 | $12.54M derived: sum of 2 quarters · filed 2026-05-07 | $18.81M derived: sum of 3 quarters · filed 2026-05-07 | $25.08M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $6.27M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $12.54M derived: sum of 2 quarters · filed 2026-02-26 | $18.81M derived: sum of 3 quarters · filed 2026-08-06 | $25.05M 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | $6.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $12.54M derived: sum of 2 quarters · filed 2026-08-06 | $18.78M 10-Q · filed 2025-11-06 | $24.96M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $6.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $12.51M 10-Q · filed 2026-08-06 | $18.69M derived: sum of 3 quarters · filed 2026-08-06 | $24.87M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $6.24M 10-Q · filed 2026-05-07 | $12.42M derived: sum of 2 quarters · filed 2026-05-07 | $18.60M derived: sum of 3 quarters · filed 2026-05-07 | $24.79M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | $6.18M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $12.36M derived: sum of 2 quarters · filed 2026-02-26 | $18.55M derived: sum of 3 quarters · filed 2026-02-26 | $24.72M 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | $6.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $12.37M derived: sum of 2 quarters · filed 2025-11-06 | $18.54M 10-Q · filed 2025-11-06 | $24.72M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-06-30 | $6.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $12.36M 10-Q · filed 2025-08-07 | $18.54M derived: sum of 3 quarters · filed 2026-02-26 | $24.72M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-03-31 | $6.17M 10-Q · filed 2025-05-08 | $12.35M derived: sum of 2 quarters · filed 2026-02-26 | $18.53M derived: sum of 3 quarters · filed 2026-02-26 | $18.76M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2023-12-31 | $6.18M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $12.36M derived: sum of 2 quarters · filed 2026-02-26 | $12.59M derived: sum of 3 quarters · filed 2026-02-26 | $12.83M 10-K · filed 2026-02-26 | ||||
| 2023-09-30 | $6.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $6.41M derived: sum of 2 quarters · filed 2024-11-07 | $6.65M 10-Q · filed 2024-11-07 | $6.88M derived: sum of 4 quarters · filed 2025-03-03 | ||||
| 2023-06-30 | $230.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $471.00K 10-Q · filed 2024-08-09 | $695.00K derived: sum of 3 quarters · filed 2025-03-03 | $921.00K derived: sum of 4 quarters · filed 2025-03-03 | ||||
| 2023-03-31 | $241.00K 10-Q · filed 2024-05-10 | $465.00K derived: sum of 2 quarters · filed 2025-03-03 | $691.00K derived: sum of 3 quarters · filed 2025-03-03 | $843.00K derived: sum of 4 quarters · filed 2025-03-03 | ||||
| 2022-12-31 | $224.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $450.00K derived: sum of 2 quarters · filed 2025-03-03 | $602.00K derived: sum of 3 quarters · filed 2025-03-03 | $954.00K 10-K · filed 2025-03-03 | $1.42M 10-K · filed 2023-03-01 | |||
| 2022-09-30 | $226.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $378.00K derived: sum of 2 quarters · filed 2023-11-08 | $730.00K 10-Q · filed 2023-11-08 | $1.09M 10-Q · filed 2022-11-08 | $871.00K derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2022-06-30 | $152.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $504.00K 10-Q · filed 2023-08-09 | $696.00K 10-Q · filed 2022-08-09 | $645.00K derived: sum of 3 quarters · filed 2024-02-29 | $1.02M derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2022-03-31 | $352.00K 10-Q · filed 2023-05-09 | $493.00K derived: sum of 2 quarters · filed 2024-02-29 | $870.00K derived: sum of 3 quarters · filed 2024-02-29 | $1.15M derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2021-12-31 | $141.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $518.00K derived: sum of 2 quarters · filed 2024-02-29 | $795.00K derived: sum of 3 quarters · filed 2024-02-29 | $1.07M 10-K · filed 2024-02-29 | $1.29M 10-K · filed 2022-03-11 | |||
| 2021-09-30 | $377.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $654.00K derived: sum of 2 quarters · filed 2022-11-08 | $930.00K 10-Q · filed 2022-11-08 | $1.20M derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2021-06-30 | $277.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $553.00K 10-Q · filed 2022-08-09 | $818.00K derived: sum of 3 quarters · filed 2023-03-01 | $1.08M derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2021-03-31 | $276.00K 10-Q · filed 2022-05-10 | $541.00K derived: sum of 2 quarters · filed 2023-03-01 | $803.00K derived: sum of 3 quarters · filed 2023-03-01 | $1.05M derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2020-12-31 | $265.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $527.00K derived: sum of 2 quarters · filed 2023-03-01 | $778.00K derived: sum of 3 quarters · filed 2023-03-01 | $1.04M 10-K · filed 2023-03-01 | ||||
| 2020-09-30 | $262.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $513.00K derived: sum of 2 quarters · filed 2021-11-09 | $771.00K 10-Q · filed 2021-11-09 | $1.03M derived: sum of 4 quarters · filed 2022-03-11 | ||||
| 2020-06-30 | $251.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $509.00K 10-Q · filed 2021-08-09 | $769.00K derived: sum of 3 quarters · filed 2022-03-11 | $1.02M derived: sum of 4 quarters · filed 2022-03-11 | ||||
| 2020-03-31 | $258.00K 10-Q · filed 2021-05-07 | $518.00K derived: sum of 2 quarters · filed 2022-03-11 | $769.00K derived: sum of 3 quarters · filed 2022-03-11 | $1.02M derived: sum of 4 quarters · filed 2022-03-11 | ||||
| 2019-12-31 | $260.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $511.00K derived: sum of 2 quarters · filed 2022-03-11 | $767.00K derived: sum of 3 quarters · filed 2022-03-11 | $1.04M 10-K · filed 2022-03-11 | ||||
| 2019-09-30 | $251.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $507.00K derived: sum of 2 quarters · filed 2020-11-06 | $777.00K 10-Q · filed 2020-11-06 | $1.04M derived: sum of 4 quarters · filed 2021-03-15 | ||||
| 2019-06-30 | $256.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $526.00K 10-Q · filed 2020-08-07 | $791.00K derived: sum of 3 quarters · filed 2021-03-15 | $1.06M derived: sum of 4 quarters · filed 2021-03-15 | ||||
| 2019-03-31 | $270.00K 10-Q · filed 2020-05-11 | $360.00K 10-Q · filed 2019-05-10 | $535.00K derived: sum of 2 quarters · filed 2021-03-15 | $806.00K derived: sum of 3 quarters · filed 2021-03-15 | $1.53M derived: sum of 4 quarters · filed 2021-03-15 | |||
| 2018-12-31 | $265.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $536.00K derived: sum of 2 quarters · filed 2021-03-15 | $1.26M derived: sum of 3 quarters · filed 2021-03-15 | $1.99M 10-K · filed 2021-03-15 | ||||
| 2018-09-30 | $271.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $993.00K derived: sum of 2 quarters · filed 2019-11-08 | $1.72M 10-Q · filed 2019-11-08 | $2.44M derived: sum of 4 quarters · filed 2020-03-16 | ||||
| 2018-06-30 | $722.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $1.45M 10-Q · filed 2019-08-09 | $2.17M derived: sum of 3 quarters · filed 2020-03-16 | $2.88M derived: sum of 4 quarters · filed 2020-03-16 | ||||
| 2018-03-31 | $729.00K 10-Q · filed 2019-05-10 | $1.45M derived: sum of 2 quarters · filed 2020-03-16 | $2.16M derived: sum of 3 quarters · filed 2020-03-16 | $2.86M derived: sum of 4 quarters · filed 2020-03-16 | ||||
| 2017-12-31 | $717.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $1.43M derived: sum of 2 quarters · filed 2020-03-16 | $2.13M derived: sum of 3 quarters · filed 2020-03-16 | $2.86M 10-K · filed 2020-03-16 | ||||
| 2017-09-30 | $713.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $1.42M derived: sum of 2 quarters · filed 2018-11-09 | $2.14M 10-Q · filed 2018-11-09 | $2.90M derived: sum of 4 quarters · filed 2019-03-15 | ||||
| 2017-06-30 | $705.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $1.43M 10-Q · filed 2018-08-09 | $2.19M derived: sum of 3 quarters · filed 2019-03-15 | $2.89M derived: sum of 4 quarters · filed 2019-03-15 | ||||
| 2017-03-31 | $721.00K 10-Q · filed 2018-05-10 | $1.49M derived: sum of 2 quarters · filed 2019-03-15 | $2.19M derived: sum of 3 quarters · filed 2019-03-15 | $2.76M derived: sum of 4 quarters · filed 2019-03-15 | ||||
| 2016-12-31 | $766.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | $1.47M derived: sum of 2 quarters · filed 2019-03-15 | $2.04M derived: sum of 3 quarters · filed 2019-03-15 | $2.52M 10-K · filed 2019-03-15 | ||||
| 2016-09-30 | $701.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $1.27M derived: sum of 2 quarters · filed 2017-11-09 | $1.75M 10-Q · filed 2017-11-09 | $2.23M derived: sum of 4 quarters · filed 2018-03-14 | ||||
| 2016-06-30 | $569.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $1.05M 10-Q · filed 2017-08-09 | $1.53M derived: sum of 3 quarters · filed 2018-03-14 | $2.01M derived: sum of 4 quarters · filed 2018-03-14 | ||||
| 2016-03-31 | $481.00K 10-Q · filed 2017-05-10 | $961.00K derived: sum of 2 quarters · filed 2018-03-14 | $1.44M derived: sum of 3 quarters · filed 2018-03-14 | $1.94M derived: sum of 4 quarters · filed 2018-03-14 | ||||
| 2015-12-31 | $480.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $959.00K derived: sum of 2 quarters · filed 2018-03-14 | $1.46M derived: sum of 3 quarters · filed 2018-03-14 | $1.94M 10-K · filed 2018-03-14 | ||||
| 2015-09-30 | $479.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $977.00K derived: sum of 2 quarters · filed 2016-11-09 | $1.46M 10-Q · filed 2016-11-09 | $1.94M derived: sum of 4 quarters · filed 2017-03-15 | ||||
| 2015-06-30 | $498.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $979.00K 10-Q · filed 2016-08-09 | $1.46M derived: sum of 3 quarters · filed 2017-03-15 | $1.94M derived: sum of 4 quarters · filed 2017-03-15 | ||||
| 2015-03-31 | $481.00K 10-Q · filed 2016-05-10 | $964.00K derived: sum of 2 quarters · filed 2017-03-15 | $1.45M derived: sum of 3 quarters · filed 2017-03-15 | $1.93M derived: sum of 4 quarters · filed 2017-03-15 | ||||
| 2014-12-31 | $483.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $964.00K derived: sum of 2 quarters · filed 2017-03-15 | $1.45M derived: sum of 3 quarters · filed 2017-03-15 | $1.92M 10-K · filed 2017-03-15 | ||||
| 2014-09-30 | $481.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | $962.00K derived: sum of 2 quarters · filed 2015-11-13 | $1.44M 10-Q · filed 2015-11-13 | $1.91M derived: sum of 4 quarters · filed 2016-03-15 | ||||
| 2014-06-30 | $481.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | $956.00K 10-Q · filed 2015-08-13 | $1.43M derived: sum of 3 quarters · filed 2016-03-15 | $1.91M derived: sum of 4 quarters · filed 2016-03-15 | ||||
| 2014-03-31 | $475.00K 10-Q · filed 2015-05-14 | $952.00K derived: sum of 2 quarters · filed 2016-03-15 | $1.43M derived: sum of 3 quarters · filed 2016-03-15 | |||||
| 2013-12-31 | $477.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $957.00K derived: sum of 2 quarters · filed 2016-03-15 | $1.91M 10-K · filed 2016-03-15 | |||||
| 2013-09-30 | $480.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | $1.43M 10-Q · filed 2014-11-13 | ||||||
| 2013-06-30 | $950.00K 10-Q · filed 2014-08-13 | |||||||
| 2012-12-31 | $1.84M 10-K · filed 2015-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |